Table 1. Newborn Screening for SMA and SCID Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Newborn Screening for SMA and SCID Market Restraints

Table 3. Newborn Screening for SMA and SCID Market Trends

Table 4. Newborn Screening for SMA and SCID Industry Policy

Table 5. Global Newborn Screening for SMA and SCID Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Newborn Screening for SMA and SCID Revenue Market Share by Company (2018-2023)

Table 7. Global Newborn Screening for SMA and SCID Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Newborn Screening for SMA and SCID Mergers & Acquisitions, Expansion Plans

Table 9. Global Newborn Screening for SMA and SCID Manufacturers Product Type

Table 10. China Newborn Screening for SMA and SCID Revenue by Company (2018-2023) & (US$ million)

Table 11. China Newborn Screening for SMA and SCID Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Newborn Screening for SMA and SCID Upstream (Raw Materials)

Table 13. Global Newborn Screening for SMA and SCID Typical Customers

Table 14. Newborn Screening for SMA and SCID Typical Distributors

Table 15. By Type, Global Newborn Screening for SMA and SCID Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Newborn Screening for SMA and SCID Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Newborn Screening for SMA and SCID Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Newborn Screening for SMA and SCID Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Newborn Screening for SMA and SCID Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Newborn Screening for SMA and SCID Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Newborn Screening for SMA and SCID Revenue Market Share, 2018-2029

Table 22. Perkinelmer Company Information, Head Office, Market Area and Industry Position

Table 23. Perkinelmer Company Profile and Main Business

Table 24. Perkinelmer Newborn Screening for SMA and SCID Models, Specifications and Application

Table 25. Perkinelmer Newborn Screening for SMA and SCID Revenue and Gross Margin, 2018-2023

Table 26. Perkinelmer Recent Developments

Table 27. Thermo Fisher Company Information, Head Office, Market Area and Industry Position

Table 28. Thermo Fisher Company Profile and Main Business

Table 29. Thermo Fisher Newborn Screening for SMA and SCID Models, Specifications and Application

Table 30. Thermo Fisher Newborn Screening for SMA and SCID Revenue and Gross Margin, 2018-2023

Table 31. Thermo Fisher Recent Developments

Table 32. ImmunoIVD Company Information, Head Office, Market Area and Industry Position

Table 33. ImmunoIVD Company Profile and Main Business

Table 34. ImmunoIVD Newborn Screening for SMA and SCID Models, Specifications and Application

Table 35. ImmunoIVD Newborn Screening for SMA and SCID Revenue and Gross Margin, 2018-2023

Table 36. ImmunoIVD Recent Developments

Table 37. Labsystems Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 38. Labsystems Diagnostics Company Profile and Main Business

Table 39. Labsystems Diagnostics Newborn Screening for SMA and SCID Models, Specifications and Application

Table 40. Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue and Gross Margin, 2018-2023

Table 41. Labsystems Diagnostics Recent Developments

List of Figure

Figure 1. Newborn Screening for SMA and SCID Picture

Figure 2. Global Newborn Screening for SMA and SCID Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Newborn Screening for SMA and SCID Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Newborn Screening for SMA and SCID Market Share of Global

Figure 5. Global Newborn Screening for SMA and SCID Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Newborn Screening for SMA and SCID Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Newborn Screening for SMA and SCID Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Newborn Screening for SMA and SCID Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Newborn Screening for SMA and SCID Industry Chain

Figure 10. Instruments

Figure 11. Kits

Figure 12. Software

Figure 13. By Type, Global Newborn Screening for SMA and SCID Revenue, 2018-2029, US$ Million

Figure 14. By Type, Global Newborn Screening for SMA and SCID Revenue Market Share, 2018-2029

Figure 15. SCID Screening

Figure 16. SMA Screening

Figure 17. By Application, Global Newborn Screening for SMA and SCID Revenue, 2018-2029, US$ Million

Figure 18. By Application, Global Newborn Screening for SMA and SCID Revenue Market Share, 2018-2029

Figure 19. By Region, Global Newborn Screening for SMA and SCID Revenue Market Share, 2018-2029

Figure 20. North America Newborn Screening for SMA and SCID Revenue & Forecasts, 2018-2029, US$ Million

Figure 21. By Country, North America Newborn Screening for SMA and SCID Revenue Market Share, 2018-2023

Figure 22. Europe Newborn Screening for SMA and SCID Revenue & Forecasts, 2018-2029, US$ Million

Figure 23. By Country, Europe Newborn Screening for SMA and SCID Revenue Market Share, 2018-2023

Figure 24. Asia Pacific Newborn Screening for SMA and SCID Revenue & Forecasts, 2018-2029, US$ Million

Figure 25. By Country/Region, Asia Pacific Newborn Screening for SMA and SCID Revenue Market Share, 2018-2023

Figure 26. South America Newborn Screening for SMA and SCID Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country, South America Newborn Screening for SMA and SCID Revenue Market Share, 2018-2023

Figure 28. Middle East & Africa Newborn Screening for SMA and SCID Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. U.S. Newborn Screening for SMA and SCID Revenue, 2018-2029, (US$ Million)

Figure 30. By Company, U.S. Newborn Screening for SMA and SCID Market Share, 2018-2023

Figure 31. By Type, U.S. Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 32. By Application, U.S. Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 33. Europe Newborn Screening for SMA and SCID Revenue, 2018-2029, (US$ Million)

Figure 34. By Company, Europe Newborn Screening for SMA and SCID Market Share, 2018-2023

Figure 35. By Type, Europe Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 36. By Application, Europe Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 37. China Newborn Screening for SMA and SCID Revenue, 2018-2029, (US$ Million)

Figure 38. By Company, China Newborn Screening for SMA and SCID Market Share, 2018-2023

Figure 39. By Type, China Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 40. By Application, China Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 41. Japan Newborn Screening for SMA and SCID Revenue, 2018-2029, (US$ Million)

Figure 42. By Company, Japan Newborn Screening for SMA and SCID Market Share, 2018-2023

Figure 43. By Type, Japan Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 44. By Application, Japan Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 45. South Korea Newborn Screening for SMA and SCID Revenue, 2018-2029, (US$ Million)

Figure 46. By Company, South Korea Newborn Screening for SMA and SCID Market Share, 2018-2023

Figure 47. By Type, South Korea Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 48. By Application, South Korea Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 49. Southeast Asia Newborn Screening for SMA and SCID Revenue, 2018-2029, (US$ Million)

Figure 50. By Company, Southeast Asia Newborn Screening for SMA and SCID Market Share, 2018-2023

Figure 51. By Type, Southeast Asia Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 52. By Application, Southeast Asia Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 53. India Newborn Screening for SMA and SCID Revenue, 2018-2029, (US$ Million)

Figure 54. By Company, India Newborn Screening for SMA and SCID Market Share, 2018-2023

Figure 55. By Type, India Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 56. By Application, India Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 57. Middle East & Asia Newborn Screening for SMA and SCID Revenue, 2018-2029, (US$ Million)

Figure 58. By Company, Middle East & Asia Newborn Screening for SMA and SCID Market Share, 2018-2023

Figure 59. By Type, Middle East & Asia Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 60. By Application, Middle East & Asia Newborn Screening for SMA and SCID Revenue Market Share, 2022 VS 2029

Figure 61. Research Methodology

Figure 62. Breakdown of Primary Interviews

Figure 63. Bottom-up Approaches

Figure 64. Top-down Approaches